Advances in psychopharmacology

Abstract

Psychopharmacologic therapy for people with mental retardation involves both treatment of identified psychiatric disorders, as well as non-specific approaches to individual or multiple behavioral symptoms. Recent work has focused on the introduction of new psychopharmacologic agents into the field; as this occurs, reviews of the literature can begin to provide data-based practice guidelines for the clinician.